Perrigo Ordinary Shares reported $2.93B in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Aphria Inc APH:CN C$ 901.16M 375.72M
Bayer BAYN:GR € 36664M 1254M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Catalent CTLT:US $ 3166M 16.4M
Coherus Biosciences CHRS:US $ 287.08M 11.83M
Corcept Therapeutics CORT:US $ 0M 0M
Eli Lilly And LLY:US $ 14736.6M 1463M
Endo International Ordinary Shares ENDP:US $ 8074.44M 26.54M
Flexion Therapeutics FLXN:US $ 220.02M 14.99M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Horizon Pharma HZNP:US $ 2560.44M 2.07M
JAZZ PHA JAZZ:US $ 6495.33M 4642.3M
Lannett LCI:US $ 590.68M 20.02M
Pacira Pharmaceuticals PCRX:US $ 321.71M 4.37M
Perrigo Ordinary Shares PRGO:US $ 2925.8M 599.5M
Phibro Animal Health PAHC:US $ 382.71M 25.92M
Prestige Brands PBH:US $ 1551.51M 65.04M
Supernus Pharmaceuticals SUPN:US $ 370.38M 14.15M
Teva Pharmaceutical TEVA:IT 21.6B 686M
Xeris Pharmaceuticals Inc XERS:US $ 87.48M 206K
Zoetis ZTS:US $ 6592M 5M